| Nov 7 |
With 66% institutional ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) is a favorite amongst the big guns
|
| Oct 30 |
Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales
|
| Oct 29 |
Utah Medical Products GAAP EPS of $3.09, revenue of $31.74M
|
| Oct 29 |
Utah Medical: Q3 Earnings Snapshot
|
| Oct 29 |
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
|
| Aug 29 |
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
|
| Aug 28 |
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
|
| Aug 16 |
Will Weakness in Utah Medical Products, Inc.'s (NASDAQ:UTMD) Stock Prove Temporary Given Strong Fundamentals?
|
| Jul 12 |
Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal
|
| Jun 21 |
Investors in Utah Medical Products (NASDAQ:UTMD) have unfortunately lost 27% over the last year
|
